Canada Life
GMAB icon

Canada Life’s Genmab GMAB Stock Holding History

Canada Life’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$168K Buy
6,261
+1,739
+38% +$52.1K ﹤0.01% 1621
2025
Q4 		$139K Buy
4,522
+1,369
+43% +$42.7K ﹤0.01% 1677
2025
Q3 		$92K Buy
3,153
+627
+25% +$15.3K ﹤0.01% 1769
2025
Q2 		$52K Buy
2,526
+262
+12% +$5.38K ﹤0.01% 1828
2025
Q1 		$44K Buy
2,264
+697
+44% +$14.6K ﹤0.01% 1871
2024
Q4 		$33K Sell
1,567
-1,143
-42% -$25.1K ﹤0.01% 1917
2024
Q3 		$66K Buy
2,710
+838
+45% +$22.4K ﹤0.01% 1913
2024
Q2 		$47K Buy
1,872
+891
+91% +$25.3K ﹤0.01% 1973
2024
Q1 		$29K Buy
981
+281
+40% +$8.26K ﹤0.01% 2056
2023
Q4 		$22K Sell
700
-244
-26% -$7.66K ﹤0.01% 2092
2023
Q3 		$33K Buy
944
+9
+1% +$343 ﹤0.01% 2082
2023
Q2 		$36K Sell
935
-655
-41% -$26.1K ﹤0.01% 2042
2023
Q1 		$60K Buy
1,590
+649
+69% +$24.9K ﹤0.01% 2041
2022
Q4 		$40K Buy
941
+141
+18% +$5.81K ﹤0.01% 2122
2022
Q3 		$26K Buy
800
+206
+35% +$7.23K ﹤0.01% 2214
2022
Q2 		$19K Buy
594
+198
+50% +$6.42K ﹤0.01% 2276
2022
Q1 		$15K Buy
396
+201
+103% +$6.9K ﹤0.01% 2397
2021
Q4 		$8K Buy
+195
New +$8.13K ﹤0.01% 2457

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Canada Life's GMAB Position: Q1 2026 in Review

Canada Life increased its Genmab (GMAB) stake by 38% in Q1 2026, buying an estimated $52.1K and bringing the position to 6,261 shares worth $168K. The position accounts for ﹤0.01% of the portfolio, ranked #1621.

Canada Life first reported a position in GMAB in Q4 2021 and has held it in 18 quarters since. 273 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Canada Life held 6,261 shares of Genmab worth $168K as of Q1 2026.
  • Canada Life bought 1,739 Genmab shares in Q1 2026, an estimated $52.1K.
  • Genmab made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1621 holding.
  • Canada Life first reported a position in Genmab in Q4 2021 and has held it in 18 quarters since.
  • 273 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.